Publications by authors named "Dirk Lok"

Claim this Profile
E
Efficacy and safety of low-dose digoxin in patients with heart failure. Rationale and design of the DECISION trial.
Dirk J van Veldhuisen, Michiel Rienstra, Arend Mosterd, A Marco Alings, Antoinette D J van Asselt, Dirk J A Lok

Eur J Heart Fail· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of regional transmural agreements to support the right care in the right place for patients with chronic heart failure-a qualitative study.
Stefan L Auener, Patrick P T Jeurissen, Dirk J A Lok, Huug J van Duijn, Petra E J van Pol

Neth Heart J· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive Decline Over Time in Patients With Systolic Heart Failure: Insights From WARCEF.
Tetz C Lee, Min Qian, Yutong Liu, Susan Graham, Douglas L Mann, Dirk J Lok

JACC Heart Fail· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulse pressure and prognosis in patients with heart failure with reduced ejection fraction.
Neeraj Shah, Min Qian, Marco R Di Tullio, Susan Graham, Douglas L Mann, Dirk J Lok

Eur J Clin Invest· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between mortality and implantable cardioverter-defibrillators by aetiology of heart failure: a propensity-matched analysis of the WARCEF trial.
Tetz C Lee, Min Qian, Lan Mu, Marco R Di Tullio, Susan Graham, Dirk J Lok

ESC Heart Fail· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Left atrial volume and cardiovascular outcomes in systolic heart failure: effect of antithrombotic treatment.
Marco R Di Tullio, Min Qian, John L P Thompson, Arthur J Labovitz, Douglas L Mann, Dirk J Lok

ESC Heart Fail· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geriatric rehabilitation in older patients with cardiovascular disease: a feasibility study.
Eléonore F van Dam van Isselt, Jan van Wijngaarden, Dirk J A Lok, Wilco P Achterberg

Eur Geriatr Med· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial).
Tetz C Lee, Min Qian, Gregory Y H Lip, Marco R Di Tullio, Susan Graham, Dirk J Lok

Am J Cardiol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Outcomes and Intervention Among Patients With Non-ST-Segment Elevation Acute Myocardial Infarction of Those With a Left Circumflex Versus Those With a Non-Left Circumflex-Related Coronary Artery (From the ELISA-3 Trial).
Erik A Badings, Renicus S Hermanides, Salem H K The, Jan-Henk E Dambrink, Saman Rasoul, Dirk J A Lok

Am J Cardiol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resting Heart Rate and Ischemic Stroke in Patients with Heart Failure.
Koki Nakanishi, Marco R Di Tullio, Min Qian, John L P Thompson, Arthur J Labovitz, Dirk J Lok

Cerebrovasc Dis· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aspirin Does Not Increase Heart Failure Events in Heart Failure Patients: From the WARCEF Trial.
John R Teerlink, Min Qian, Natalie A Bello, Ronald S Freudenberger, Bruce Levin, Dirk J Lok

JACC Heart Fail· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-year outcome after early or late Intervention in non-ST elevation acute coronary syndrome.
Erik A Badings, Wouter S Remkes, Salem H K The, Jan-Henk E Dambrink, Geert Tjeerdsma, Dirk J A Lok

Open Heart· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Echocardiographic Factors Associated With New-Onset Atrial Fibrillation in Heart Failure　- Subanalysis of the WARCEF Trial.
Tomoko S Kato, Marco R Di Tullio, Min Qian, Mengfei Wu, John L P Thompson, Dirk J Lok

Circ J· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early or late intervention in patients with transient ST-segment elevation acute coronary syndrome: Subgroup analysis of the ELISA-3 trial.
Erik A Badings, Wouter S Remkes, Salem H K The, Jan-Henk E Dambrink, Geert Tjeerdsma, Dirk J A Lok

Catheter Cardiovasc Interv· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What Are Effective Program Characteristics of Self-Management Interventions in Patients With Heart Failure? An Individual Patient Data Meta-analysis.
Nini H Jonkman, Heleen Westland, Rolf H H Groenwold, Susanna Ågren, Manuel Anguita, Dirk J A Lok

J Card Fail· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CHA DS -VASc score and adverse outcomes in patients with heart failure with reduced ejection fraction and sinus rhythm.
Siqin Ye, Min Qian, Bo Zhao, Richard Buchsbaum, Ralph L Sacco, Dirk J Lok

Eur J Heart Fail· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The first prognostic model for stroke and death in patients with systolic heart failure.
Ronald S Freudenberger, Bin Cheng, Douglas L Mann, John L P Thompson, Ralph L Sacco, Dirk J Lok

J Cardiol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial.
Marco R Di Tullio, Min Qian, John L P Thompson, Arthur J Labovitz, Douglas L Mann, Dirk J Lok

Stroke· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do Self-Management Interventions Work in Patients With Heart Failure? An Individual Patient Data Meta-Analysis.
Nini H Jonkman, Heleen Westland, Rolf H H Groenwold, Susanna Ågren, Felipe Atienza, Dirk J A Lok

Circulation· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or Aspirin.
Siqin Ye, Bin Cheng, Gregory Y H Lip, Richard Buchsbaum, Ralph L Sacco, Dirk J Lok

Am J Cardiol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent stroke in the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial.
Patrick M Pullicino, Min Qian, Ralph L Sacco, Ron Freudenberger, Susan Graham, Dirk J Lok

Cerebrovasc Dis· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive function in ambulatory patients with systolic heart failure: insights from the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial.
Susan Graham, Siqin Ye, Min Qian, Alexandra R Sanford, Marco R Di Tullio, Dirk J Lok

PLoS One· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy.
Shunichi Homma, John L P Thompson, Min Qian, Siqin Ye, Marco R Di Tullio, Dirk J Lok

Circ Heart Fail· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of quality of life with anticoagulant control in patients with heart failure: the Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) trial.
Jonathan A Shaffer, John L P Thompson, Bin Cheng, Siqin Ye, Gregory Y H Lip, Dirk J Lok

Int J Cardiol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up in optimally treated and stable heart failure patients: primary care vs. heart failure clinic. Results of the COACH-2 study.
Marie Louise A Luttik, Tiny Jaarsma, Peter Paul van Geel, Maaike Brons, Hans L Hillege, Dirk J A Lok

Eur J Heart Fail· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis